908 Devices (MASS) Share-based Compensation (2020 - 2026)
908 Devices (MASS) posted quarterly Share-based Compensation of $12.0 million for Q1 2026, up 440.54% year-over-year from $2.2 million in Q1 2025, and up 357.84% quarter-over-quarter from $2.6 million in Q4 2025.
908 Devices (MASS) Share-based Compensation (2020 - 2026) Analysis & Trends
908 Devices (MASS) has reported Share-based Compensation for 7 consecutive years, with $12.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation rose 440.54% year-over-year to $12.0 million; the TTM figure through Mar 2026 stood at $12.0 million (up 92.18% YoY), while the FY2025 annual figure was $9.7 million, up 15.04% from the prior year.
- Share-based Compensation climbed to $12.0 million in Q1 2026 per MASS's latest filing, from $2.6 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $12.0 million in Q1 2026 and bottomed at -$505000.0 in Q4 2024.
- Historically, Share-based Compensation has averaged $3.0 million across 5 years, with a median of $2.2 million in 2024.
- Annual changes were most pronounced in 2024 — Share-based Compensation tumbled 121.59% — and 2025, when it soared 619.01%.
- 908 Devices' Share-based Compensation stood at $2.0 million in 2022, then gained by 16.72% to $2.3 million in 2023, then slumped by 121.59% to -$505000.0 in 2024, then jumped by 619.01% to $2.6 million in 2025, then surged by 357.84% to $12.0 million in 2026.
- Business Quant data shows MASS's Share-based Compensation at $12.0 million in Q1 2026, $2.6 million in Q4 2025, and $9.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.80 Mn |
| 10 | 908 Devices | 387.65 Mn | 286.12 Mn | 8.34 Mn | 2.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.31 Mn |
| Jun 30, 2026 | 2.31 Mn |
| Mar 31, 2026 | 12.00 Mn |
| Mar 31, 2026 | 12.00 Mn |
| Dec 31, 2025 | 2.62 Mn |
| Dec 31, 2025 | 2.62 Mn |
| Sep 30, 2025 | 9.80 Mn |
| Sep 30, 2025 | 9.80 Mn |
| Jun 30, 2025 | 2.34 Mn |
| Jun 30, 2025 | 2.34 Mn |
| Mar 31, 2025 | 2.22 Mn |
| Mar 31, 2025 | 2.22 Mn |
| Dec 31, 2024 | -505,000.00 |
| Dec 31, 2024 | -505,000.00 |
| Sep 30, 2024 | 2.30 Mn |
| Sep 30, 2024 | 2.30 Mn |
| Jun 30, 2024 | 2.23 Mn |
| Jun 30, 2024 | 2.23 Mn |
| Mar 31, 2024 | 1.84 Mn |
| Mar 31, 2024 | 1.84 Mn |